| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |